Swissport’s Basel cargo warehouse receives pharma certification from IATA

May 05, 2018: Ground handler Swissport Cargo Services has received IATA Center of Excellence for Independent Validators (CEIV) certificate for particularly sensitive pharmaceutical logistics at Basel’s EuroAirport. Swissport’s Basel warehouse is the company's sixth CEIV certified cargo facility. “The CEIV certification underlines the attractiveness of our services at Switzerland's most modern air freight terminal,” says […]

Swissport’s Basel cargo warehouse receives pharma certification from IATA
X

May 05, 2018: Ground handler Swissport Cargo Services has received IATA Center of Excellence for Independent Validators (CEIV) certificate for particularly sensitive pharmaceutical logistics at Basel’s EuroAirport. Swissport’s Basel warehouse is the company's sixth CEIV certified cargo facility.

“The CEIV certification underlines the attractiveness of our services at Switzerland's most modern air freight terminal,” says Nils Knudsen, chief commercial officer of Swissport International.

Basel is one of the most important cargo locations of Swissport. It handled some 47,000 tonnes in 2017.

Since the opening of the warehouse in 2015, Swissport has continuously expanded its on-site offering. The facility features 7,500 square metres of temperature-controlled surface, with a temperature range of +15 to +25 degrees Celsius. Additionally there are special cooling units for pharmaceuticals ensuring a temperature between +2 and +8 and a unit for goods which require a constant temperature of -20 degrees Celcius.

Due to an exclusive direct access to the Tarmac, Swissport can move pharmaceuticals within an average of two minutes from its temperature-controlled warehouse to the aircraft.

Swissport is investing at other European logistics hubs, too. In April 2018, the company announced its plan for a large-scale expansion of its cargo infrastructure at Frankfurt airport by signing a long-term lease agreement for a new facility at CargoCity South.

Read Full Article
Next Story
Share it